Healthpeak Properties (NYSE:DOC – Get Free Report) updated its FY24 earnings guidance on Thursday. The company provided EPS guidance of $1.79-1.81 for the period, compared to the consensus EPS estimate of $1.79. Healthpeak Properties also updated its FY 2024 guidance to 1.560-1.580 EPS.
Healthpeak Properties Price Performance
Shares of Healthpeak Properties stock opened at $22.29 on Friday. The stock has a market cap of $15.59 billion, a P/E ratio of 47.43, a P/E/G ratio of 3.30 and a beta of 1.14. The company has a debt-to-equity ratio of 0.91, a quick ratio of 0.70 and a current ratio of 0.70. The stock’s fifty day moving average is $22.26 and its 200 day moving average is $20.67. Healthpeak Properties has a one year low of $15.24 and a one year high of $23.26.
Healthpeak Properties (NYSE:DOC – Get Free Report) last posted its quarterly earnings results on Thursday, July 25th. The real estate investment trust reported $0.21 earnings per share for the quarter, missing analysts’ consensus estimates of $0.44 by ($0.23). Healthpeak Properties had a return on equity of 3.51% and a net margin of 11.93%. The firm had revenue of $695.50 million during the quarter, compared to the consensus estimate of $665.11 million. During the same quarter in the previous year, the company earned $0.45 earnings per share. The business’s revenue for the quarter was up 27.5% compared to the same quarter last year. Sell-side analysts anticipate that Healthpeak Properties will post 1.79 earnings per share for the current year.
Healthpeak Properties Dividend Announcement
Analyst Upgrades and Downgrades
Several research firms recently commented on DOC. Wedbush raised their price target on shares of Healthpeak Properties from $22.00 to $25.00 and gave the stock an “outperform” rating in a research note on Monday, July 29th. Scotiabank increased their price objective on Healthpeak Properties from $23.00 to $24.00 and gave the stock a “sector outperform” rating in a research note on Monday, September 9th. Wells Fargo & Company reaffirmed an “equal weight” rating and set a $23.00 target price (up from $22.00) on shares of Healthpeak Properties in a research report on Tuesday, October 1st. Royal Bank of Canada increased their price target on Healthpeak Properties from $22.00 to $25.00 and gave the stock an “outperform” rating in a research report on Tuesday, July 30th. Finally, Deutsche Bank Aktiengesellschaft upgraded Healthpeak Properties from a “hold” rating to a “buy” rating and lifted their price objective for the company from $20.00 to $28.00 in a report on Monday, October 21st. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, Healthpeak Properties has a consensus rating of “Moderate Buy” and an average target price of $22.62.
View Our Latest Research Report on Healthpeak Properties
Healthpeak Properties Company Profile
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Featured Articles
- Five stocks we like better than Healthpeak Properties
- The Most Important Warren Buffett Stock for Investors: His Own
- Real Estate Sector Outperforms: 3 Stocks to Gain Exposure
- High Flyers: 3 Natural Gas Stocks for March 2022
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- Insider Trades May Not Tell You What You Think
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.